One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-137694
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 25 |
Affiliation: Hokkaido University, Incyte (United States), Novartis (Switzerland), Fred Hutch Cancer Center, Bambino Gesù Children's Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, Sapienza University of Rome, King Faisal Specialist Hospital & Research Centre, Tel Aviv Sourasky Medical Center, University Medical Center Freiburg, Tris Pharma (United States), CRUK Lung Cancer Centre of Excellence, University College London, Cancer Institute (WIA), Spedali Civili di BresciaRuxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients with Steroid-Refractory/Steroid-Dependent Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
